CollPlant Biotechnologies Ltd. (CLGN)
0.401
0.00 (0.00%)
USD |
NASDAQ |
Jun 02, 16:00
0.401
0.00 (0.00%)
After-Hours: 20:00
CollPlant Biotechnologies EPS Diluted (Quarterly) : -0.2253 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| Perspective Therapeutics, Inc. | -0.2528 |
| MiMedx Group, Inc. | -0.0732 |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.097M |
| Revenue (Quarterly) | 0.073M |
| Total Expenses (Quarterly) | 3.17M |
| Enterprise Value | 3.802M |
| Gross Profit Margin (Quarterly) | -620.5% |
| Profit Margin (Quarterly) | -4.24K% |
| Earnings Yield | -257.4% |
| Normalized Earnings Yield | -257.41 |